Phoenix Financial’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $633M | Buy |
|
|||||
2025
Q1 | $422M | Buy |
|
|||||
2024
Q4 | $468M | Sell |
|
|||||
2024
Q3 | $407M | Sell |
|
|||||
2024
Q2 | $413M | Sell |
|
|||||
2024
Q1 | $488M | Buy |
|
|||||
2023
Q4 | $404M | Sell |
|
|||||
2023
Q3 | $352M | Buy |
|
|||||
2023
Q2 | $254M | Buy |
|
|||||
2023
Q1 | $196M | Sell |
|
|||||
2022
Q4 | $202M | Buy |
|
|||||
2022
Q3 | $163M | Buy |
|
|||||
2022
Q2 | $139M | Buy |
|
|||||
2022
Q1 | $157M | Buy |
|
|||||
2021
Q4 | $122M | Buy |
|
|||||
2021
Q3 | $138M | Buy |
|
|||||
2021
Q2 | $114M | Sell |
|
|||||
2021
Q1 | $134M | Buy |
|
|||||
2020
Q4 | $83.1M | Sell |
|
|||||
2020
Q3 | $94.7M | Sell |
|
|||||
2020
Q2 | $137M | Buy |
|
|||||
2020
Q1 | $99.3M | Buy |
|
|||||
2019
Q4 | $64.2M | Buy |
|
|||||
2019
Q3 | $34.3M | Buy |
|